Proteomics-Based Identification of Anchorless Cell Wall Proteins as Vaccine Candidates againstStaphylococcus aureus
- 1 July 2009
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 77 (7) , 2719-2729
- https://doi.org/10.1128/iai.00617-08
Abstract
Staphylococcus aureus is an important human pathogen with increasing clinical impact due to the extensive spread of antibiotic-resistant strains. Therefore, development of a protective polyvalent vaccine is of great clinical interest. We employed an intravenous immunoglobulin (IVIG) preparation as a source of antibodies directed against anchorless S. aureus surface proteins for identification of novel vaccine candidates. In order to identify such proteins, subtractive proteome analysis (SUPRA) of S. aureus anchorless cell wall proteins was performed. Proteins reacting with IVIG but not with IVIG depleted of S. aureus-specific opsonizing antibodies were considered vaccine candidates. Nearly 40 proteins were identified by this preselection method using matrix-assisted laser desorption ionization-time of flight analysis. Three of these candidate proteins, enolase (Eno), oxoacyl reductase (Oxo), and hypothetical protein hp2160, were expressed as glutathione S-transferase fusion proteins, purified, and used for enrichment of corresponding immunoglobulin Gs from IVIG by affinity chromatography. Use of affinity-purified anti-Eno, anti-Oxo, and anti-hp2160 antibodies resulted in opsonization, phagocytosis, and killing of S. aureus by human neutrophils. High specific antibody titers were detected in mice immunized with recombinant antigens. In mice challenged with bioluminescent S. aureus, reduced staphylococcal spread was measured by in vivo imaging. The recovery of S. aureus CFU from organs of immunized mice was diminished 10- to 100-fold. Finally, mice immunized with hp2160 displayed statistically significant higher survival rates after lethal challenge with clinically relevant S. aureus strains. Taken together, our data suggest that anchorless cell wall proteins might be promising vaccine candidates and that SUPRA is a valuable tool for their identification.Keywords
This publication has 65 references indexed in Scilit:
- Antibodies to Capsular Polysaccharide and Clumping Factor A Prevent Mastitis and the Emergence of Unencapsulated and Small-Colony Variants ofStaphylococcus aureusin MiceInfection and Immunity, 2008
- The Surface-Exposed Carboxyl Region of Mycoplasma pneumoniae Elongation Factor Tu Interacts with FibronectinInfection and Immunity, 2008
- Characterization of IsaA and SceD, Two Putative Lytic Transglycosylases of Staphylococcus aureusJournal of Bacteriology, 2007
- Vaccine assembly from surface proteins ofStaphylococcus aureusProceedings of the National Academy of Sciences, 2006
- Identification of Staphylococcus aureus Proteins Recognized by the Antibody-Mediated Immune Response to a Biofilm InfectionInfection and Immunity, 2006
- Identification of enolase as a laminin-binding protein on the surface of Staphylococcus aureusMicrobes and Infection, 2004
- Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureusProceedings of the National Academy of Sciences, 2002
- Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinaseFEBS Letters, 2002
- Monitoring of two intravenous immunoglobulin preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patientsJournal of Pharmaceutical and Biomedical Analysis, 2000
- Rapid identification of proteins by peptide-mass fingerprintingCurrent Biology, 1993